Literature DB >> 15380361

Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.

Dineshkumar Thotala1, Elizabeth A Schafer, Parithosh K Tungaturthi, Biswanath Majumder, Michelle L Janket, Marc Wagner, Alagarsamy Srinivasan, Simon Watkins, Velpandi Ayyavoo.   

Abstract

HIV-1 Vpr has been shown to transactivate LTR-directed expression through its interaction with several proteins of cellular origin including the glucocorticoid receptor (GR). Upon activation, steroid receptors bind to proteins containing the signature motif LxxLL, translocate into the nucleus, bind to their response element, and activate transcription. The presence of such motifs in HIV-1 Vpr has prompted us to undertake the analysis of the role of specific leucine residue(s) involved in Vpr-GR interaction, subcellular localization and its effect on Vpr-GR-mediated transactivation. The individual leucine residues present in H I, II, and III were mutated in the Vpr molecule and evaluated for their ability to interact with GR, transactivate GRE and HIV-1 LTR promoters, and their colocalization with GR. While Vpr mutants L42 and L67 showed reduced activation, substitutions at L20, L23, L26, L39, L64, and L68 exhibited a similar and slightly higher level of activation compared to Vprwt. Interestingly, a substitution at residue L22 resulted in a significantly higher GRE and HIV-1 LTR transactivation (8- to 11-fold higher) in comparison to wild type. Confocal microscopy indicated that Vpr L22A exhibited a distinct condensed nuclear localization pattern different from the nuclear/perinuclear pattern noted with Vprwt. Further, electrophoretic mobility shift assay (EMSA) revealed that the VprL22A-GR complex had higher DNA-binding activity when compared to the wild type Vpr-GR complex. These results suggest a contrasting role for the leucine residues on HIV-1 LTR-directed transactivation dependent upon their location in Vpr. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380361     DOI: 10.1016/j.virol.2004.07.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.

Authors:  Elizabeth D A Wheeler; Cristian L Achim; Velpandi Ayyavoo
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

2.  Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.

Authors:  Eugene Boon Beng Ong; Nobumoto Watanabe; Akiko Saito; Yushi Futamura; Khaled Hussein Abd El Galil; Atsushi Koito; Nazalan Najimudin; Hiroyuki Osada
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

3.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

4.  HIV-1 Vpr redirects host ubiquitination pathway.

Authors:  Sakshi Arora; Sachin Verma; Akhil C Banerjea
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

5.  Human immunodeficiency virus (HIV-1) Vpr induced downregulation of NHE1 induces alteration in intracellular pH and loss of ERM complex in target cells.

Authors:  Michelle L Janket; Jeremy S DeRicco; LuAnn Borowski; Velpandi Ayyavoo
Journal:  Virus Res       Date:  2007-03-08       Impact factor: 3.303

Review 6.  HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.

Authors:  Michael Kogan; Jay Rappaport
Journal:  Retrovirology       Date:  2011-04-13       Impact factor: 4.602

7.  Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.

Authors:  R Anthony Barnitz; Benjamin Chaigne-Delalande; Diane L Bolton; Michael J Lenardo
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

8.  Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  Virol J       Date:  2011-08-10       Impact factor: 4.099

Review 9.  Genetic architecture of HIV-1 genes circulating in north India & their functional implications.

Authors:  Ujjwal Neogi; Vikas Sood; Larence Ronsard; Jyotsna Singh; Sneh Lata; V G Ramachandran; S Das; Ajay Wanchu; Akhil C Banerjea
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

10.  Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.

Authors:  Courtney Zych; Alexander Domling; Velpandi Ayyavoo
Journal:  Drug Des Devel Ther       Date:  2013-05-24       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.